Tango Therapeutics Inc
TNGX
$22.70+2.30%
End of day · as of Oct 15, 2026, 8:00 PM ET
Mkt cap
$5.36B
EV/Sales
84.1
P/E ratio
N/A
FY2025 Revenue
$62.38M
EPS (TTM)
$-0.84
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-162.85%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
Latest reported TNGX revenue for 2025-12-31 was $62.4M. Net income was -$101.6M. Revenue was up 48.3% from 2024-12-31 to 2025-12-31. TNGX currently screens at market cap $5.36B.
Use this TNGX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TNGX income, balance, and cash tables.
Tango Therapeutics Inc (TNGX) is a biotechnology company in the Healthcare sector.
Latest cached Tango Therapeutics Inc (TNGX) revenue for Dec 31, 2025 was $62.4M. Net income was -$101.6M. Statements: https://lician.com/financials/tngx
Tango Therapeutics Inc (TNGX) market capitalization is $5.36B on the latest cached snapshot.
Tango Therapeutics Inc (TNGX) cached previous close $22.19; day range $22.27 – $22.79; volume 2,903,374. Session quote: https://lician.com/quote/tngx
Tango Therapeutics Inc (TNGX) latest cached earnings event is "TNGX earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TNGX filing is 8-K · Aug 11, 2026. Filings: https://lician.com/sec/tngx